Mustang Bio earnings were -$3.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest MBIO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$1.1M, up 12.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MBIO reported annual earnings of -$1.9M, with -87.8% growth.
On MBIO's earnings call on Aug 14, 2026, Mustang Bio (NASDAQ: MBIO) reported Q2 2026 earnings per share (EPS) of -$0.16, up 15.79% year over year. Total MBIO earnings for the quarter were -$1.07 million. In the same quarter last year, Mustang Bio's earnings per share (EPS) was -$0.19.
As of the last Mustang Bio earnings report, Mustang Bio is currently losing money. Mustang Bio's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$3.03 million, a 7.45% decrease year over year.
What was MBIO's earnings growth in the past year?
As of Mustang Bio's earnings date in Aug 14, 2026, Mustang Bio's earnings has grown year over year. MBIO earnings in the past year totalled -$3.03 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.